Description     Claims  

US61534390   [0001] 
US61535992B   [0001] 
US20080207616A1   [0005] 
US20110172245A1   [0006] 
US5846514A   [0080]  [0080] 
US6334997B   [0080]  [0080] 
US5323907A   [0167] 
US5052558A   [0167] 
US5033252A   [0167] 
WO0194341A   [0177] 
WO0047212A   [0177] 
WO9722596A   [0177] 
WO9730035A   [0177] 
WO9732856A   [0177] 
WO9813354A   [0177] 
WO9902166A   [0177] 
WO0040529A   [0177] 
WO0041669A   [0177] 
WO0192224A   [0177] 
WO0204434A   [0177] 
WO0208213A   [0177] 

Recent Advances in the Synthesis and Applications of Radiolabeled Compounds for Drug Discovery and Development   [0081] 
The Synthesis of Radiolabeled Compounds via Organometallic Intermediates   [0081] 
Anthony. Synthesis of radiolabeled compounds   [0081] 
Prodrugs as Novel Delivery Systems   [0085] 
Design of Prodrugs   [0085] 
Green's Protective Groups in Organic Synthesis   [0088] 
Cross-Coupling Reactions: A Practical Guide   [0135] 
Remington: The Science and Practice of Pharmacy   [0137] 
Remington's Pharmaceutical Sciences   [0137] 
Pharmaceutical Dosage Forms   [0137] 
Pharmaceutical Dosage Forms and Drug Delivery Systems   [0137] 
J. Med. Chern.   [0177] 
Critical reviews in oncology/haematology   [0177] 
Journal of Immunological Methods   [0517]